Skip to content
In English |
En español
Search
Understanding Cancer Series: Estrogen Receptors/SERMs
< Back to Main
Posted:
01/28/2005
Updated:
04/27/2006
Reviewed:
09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
New Study of Targeted Therapies for Breast Cancer
The Nation's Investment in Cancer Research FY 2009
Cancer Trends Progress Report: 2007 Update
Past Highlights
Estrogen Receptors/SERMs
Slide Number and Title
What Are Estrogens?
Estrogen Target Tissues
Estrogen Receptors
Estrogen Receptors Trigger Gene Activation
Estrogen-Induced Changes in Cell Behavior
Estrogen-Induced Stimulation of Cell Proliferation
Estrogen and Cancer
Estrogen and Breast Cancer
Cancer Arises From DNA Mutations In Cells
Estrogen-Induced Proliferation of Existing Mutant Cells
Estrogen-Induced Proliferation and Spontaneous New Mutations
Estrogen and Uterine Cancer
Antiestrogens
SERMs
Tamoxifen and Cancer
Tamoxifen and Breast Cancer Treatment
Estrogen Receptor-Negative Breast Cancer
Tamoxifen and Breast Cancer Prevention
Tamoxifen as a Cause of Uterine Cancer
The Need for Better SERMs
Estrogen Replacement During Menopause
Estrogen Plus Progesterone Replacement
Search for the Perfect SERM
Raloxifene and the Prevention of Osteoporosis
Raloxifene and Risk of Invasive Breast Cancer
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute